Literature DB >> 24443957

Puberty as an accelerator for diabetes complications.

Yoon Hi Cho1, Maria E Craig, Kim C Donaghue.   

Abstract

Much is written about how difficult it is to deal with diabetes during adolescence, and rightly so. Less is understood as to how puberty may be an accelerator of vascular complications. With the increase in childhood diabetes, complication risks need to be revisited in relation to puberty and the secular increase in adiposity. Recent data suggest greater risk for severe vascular complications in those with diabetes during puberty, compared with young people who develop diabetes after puberty. It is also widely recognized that higher hemoglobin A1c (HbA1c) results are often seen during the pubertal period. This article will review complication outcomes in relation to puberty and examine mechanisms by which puberty may modify risk above glycemic exposure, and possible gender disparities in the risk of complications in the adolescent period.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adolescent diabetes; androgens; insulin resistance; puberty; vascular complications

Mesh:

Substances:

Year:  2014        PMID: 24443957     DOI: 10.1111/pedi.12112

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  35 in total

1.  Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.

Authors:  Danalea V Skarra; Angelina Hernández-Carretero; Alissa J Rivera; Arya R Anvar; Varykina G Thackray
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

2.  Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.

Authors:  Sophia Y Wang; Chris A Andrews; William H Herman; Thomas W Gardner; Joshua D Stein
Journal:  Ophthalmology       Date:  2016-11-30       Impact factor: 12.079

3.  Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes.

Authors:  Megan M Kelsey; Petter Bjornstad; Kim McFann; Kristen Nadeau
Journal:  Pediatr Diabetes       Date:  2015-01-21       Impact factor: 4.866

4.  Achieving International Society for Pediatric and Adolescent Diabetes and American Diabetes Association clinical guidelines offers cardiorenal protection for youth with type 1 diabetes.

Authors:  Petter Bjornstad; Laura Pyle; Nhung Nguyen; Janet K Snell-Bergeon; Franziska K Bishop; R Paul Wadwa; David M Maahs
Journal:  Pediatr Diabetes       Date:  2015-02       Impact factor: 4.866

Review 5.  Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management.

Authors:  Tyger Lin; Rose A Gubitosi-Klug; Roomasa Channa; Risa M Wolf
Journal:  Curr Diab Rep       Date:  2021-12-13       Impact factor: 4.810

6.  Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents.

Authors:  Lorraine E Levitt Katz; Kevin A Gralewski; Pamela Abrams; Preneet C Brar; Paul R Gallagher; Terri H Lipman; Lee J Brooks; Dorit Koren
Journal:  Pediatr Diabetes       Date:  2014-12-10       Impact factor: 4.866

7.  Clustering of cardio-metabolic risk factors in parents of adolescents with type 1 diabetes and microalbuminuria.

Authors:  M Loredana Marcovecchio; Päivi H Tossavainen; Katharine Owen; Catherine Fullah; Paul Benitez-Aguirre; Stefano Masi; Ken Ong; Helen Nguyen; Scott T Chiesa; R Neil Dalton; John Deanfield; David B Dunger
Journal:  Pediatr Diabetes       Date:  2017-03-08       Impact factor: 4.866

8.  The dose-response effect of insulin sensitivity on albuminuria in children according to diabetes type.

Authors:  Amy K Mottl; Jasmin Divers; Dana Dabelea; David M Maahs; Lawrence Dolan; David Pettitt; Santica Marcovina; Giuseppina Imperatore; Catherine Pihoker; Michael Mauer; Elizabeth J Mayer-Davis
Journal:  Pediatr Nephrol       Date:  2016-01-11       Impact factor: 3.714

Review 9.  Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates.

Authors:  Kalie L Tommerdahl; Allison L B Shapiro; Edward J Nehus; Petter Bjornstad
Journal:  Pediatr Nephrol       Date:  2021-04-14       Impact factor: 3.714

10.  Overweight and obesity in type 1 diabetes is not associated with higher ghrelin concentrations.

Authors:  Behiye Özcan; Patric J D Delhanty; Martin Huisman; Jenny A Visser; Sebastian J Neggers; Aart Jan van der Lely
Journal:  Diabetol Metab Syndr       Date:  2021-07-22       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.